###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
SDF1 Gene Variation Is Associated with Circulating SDF1alpha Level and Endothelial Progenitor Cell Number-The Bruneck Study
###end article-title 0
###begin p 1
Conceived and designed the experiments: QX MJ QX. Performed the experiments: QX SY FO AM JW SK. Analyzed the data: QX SY SK. Contributed reagents/materials/analysis tools: QX MJ QX. Wrote the paper: QX SY SK QX.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
Stromal cell-derived factor-1 (SDF1) and its receptor CXC chemokine receptor 4 (CXCR4) play a critical role in progenitor cell homing, mobilization and differentiation. It would be interesting to assess the predictive value of SDF-1alpha level for EPC number, and to ascertain whether there is a relationship between SDF1 gene variation, plasma SDF-1alpha level, and the number and function of circulating EPCs. We also tested whether EPC number and function was related to CXCR4 gene variation.
###end p 3
###begin title 4
Methodology and Principal Findings
###end title 4
###begin p 5
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 733 737 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
We genotyped a cohort of individuals who participated in the Bruneck Study for single nucleotide polymorphisms (SNPs) in the SDF1 and CXCR4 genes, and measured blood SDF1alpha level as well as EPC number and function. SDF1alpha levels were correlated with age, gender, alcohol consumption, circulating reticulocyte numbers, and concentrations of matrix metalloproteinase-9, C-reactive protein, cystatin C, fibrinogen and homocytein. In blood samples taken in 2005, EPC number was inversely associated with SDF1alpha level (p<0.001). EPC number in 2005 was also inversely associated with SDF1alpha level in 2000 (p = 0.009), suggesting a predictive value of plasma SDF1alpha level for EPC number. There was an association between the SDF1 gene rs2297630 SNP A/A genotype, increased SDF1alpha level (p = 0.002) and lower EPC number (p = 0.006).
###end p 5
###begin title 6
Conclusions
###end title 6
###begin p 7
Our data indicate that a SDF1 gene variation (rs2297630) has an influence on SDF1alpha level and circulating EPC number, and that plasma SDF1alpha level is a predictor of EPC number.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 255 258 255 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Asahara1">[1]</xref>
###xml 349 352 349 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kalka1">[2]</xref>
###xml 354 357 354 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Takahashi1">[3]</xref>
###xml 475 478 475 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kalka1">[2]</xref>
###xml 480 483 480 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Takahashi1">[3]</xref>
###xml 605 608 605 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kawamoto1">[4]</xref>
###xml 799 802 799 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Britten1">[5]</xref>
###xml 804 807 804 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Schachinger1">[6]</xref>
###xml 927 930 927 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Vasa1">[7]</xref>
###xml 931 934 931 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Hill1">[9]</xref>
###xml 1065 1069 1065 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Fadini1">[10]</xref>
###xml 1071 1075 1071 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Tepper1">[11]</xref>
###xml 1087 1091 1087 1091 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kondo1">[12]</xref>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Grisar1">[13]</xref>
###xml 1337 1341 1337 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Choi1">[14]</xref>
###xml 1467 1471 1467 1471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Ghani1">[15]</xref>
###xml 1500 1504 1500 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Fadini1">[10]</xref>
###xml 1543 1547 1543 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Foresta1">[16]</xref>
###xml 1894 1898 1894 1898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xiao1">[17]</xref>
###xml 695 703 <span type="species:ncbi:9606">patients</span>
###xml 994 1002 <span type="species:ncbi:9606">patients</span>
###xml 1207 1215 <span type="species:ncbi:9606">patients</span>
###xml 1446 1454 <span type="species:ncbi:9606">patients</span>
###xml 1509 1517 <span type="species:ncbi:9606">patients</span>
Asahara and colleagues in 1997 demonstrated for the first time that purified CD34 positive haematopoietic progenitor cells from peripheral blood could differentiate, ex-vivo, into an endothelial phenotype and were named Endothelial Progenitor Cells (EPCs)[1]. Growing evidence indicates that EPCs play a major role in angiogenesis and vasculogenesis[2], [3]. Indeed, mobilized EPCs can promote new blood vessel formation in ischaemic tissues, enhancing perfusion and recovery[2], [3]. Ex vivo expanded EPCs isolated from peripheral blood can also incorporate into the site of myocardial neovascularization[4], and intracoronary infusion of peripheral blood or bone marrow-derived progenitors in patients with acute myocardial infarction was shown to significantly enhance post-infarction remodelling[5], [6]. Moreover, EPC numbers have a prognostic value and can be used as a predictive biomarker in the cardiovascular diseases[7]-[9]. Other investigators have also shown reduced EPC number in patients with risk factors for cardiovascular diseases such as diabetes[10], [11] and smoking[12], with cessation of smoking resulting in a return of EPC numbers to normal. EPC number is also reduced in groups of patients known to be at higher risk of cardiovascular disease such as those with rheumatoid arthritis[13] or chronic renal failure[14]. EPC number is also known to be reduced in established non-coronary cardiovascular disorders such as in patients with strokes[15], peripheral vascular disease[10] and patients with erectile dysfunction[16]. However, our recent data from a population-based, longitudinal study refuted the traditional view that the EPC number is negatively related to cardiovascular risk factors. We showed that changes of EPC numbers are loosely associated with certain risk factors for the cardiovascular disease and not directly associate with the disease development[17].
###end p 9
###begin p 10
###xml 233 237 233 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Nagasawa1">[18]</xref>
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Zou1">[20]</xref>
###xml 490 494 490 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Heissig1">[21]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Moore1">[23]</xref>
###xml 716 720 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Yamaguchi1">[24]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Hiasa1">[25]</xref>
###xml 815 819 811 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-DeFalco1">[26]</xref>
###xml 1437 1441 1413 1417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xiao1">[17]</xref>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 1072 1078 <span type="species:ncbi:9606">humans</span>
###xml 1431 1437 <span type="species:ncbi:9606">humans</span>
Animal studies have indicated that SDF1 (also known as CXC chemokine ligans 12) and its receptor CXC chemokine receptor 4 (CXCR4) plays a critical role in progenitor cell homing, mobilization and differentiation. Inactivation of the SDF1 or CXCR4 gene in mice led to early embryonic lethality due to abnormality in the cerebellar and gastrointestinal vasculature and in hematopoiesis development[18]-[20]. The number of circulating hematopoietic stem cells (HSCs) or EPCs were increased by SDF1 gene transfer using the adenovirus infection technique[21]-[23]. Overexpression of SDF1 in ischemic tissues has been found to enhance EPC recruitment from peripheral blood and to induce neoangiogenesis in ischemic tissues[24], [25]. Recent evidence also suggests that SDF1alpha is a driving force for EPC differentiation[26]. All these findings from animal studies strongly suggest that SDF1alpha has a crucial role in stem/progenitor cell mobilization, differentiation, and injured tissues-specific homing. However, it remained unknown whether SDF1alpha played such a role in humans. Therefore, we recently examined the levels of SDF1alpha and several angiogenic cytokines in relation to circulating EPC numbers in a population-based study. We found that plasma levels of SDF1alpha, but not VEGF or G-CSF, were strongly associated with EPC number and function, suggesting a role of SDF1alpha in EPC mobilization and differentiation in humans[17]. In that study, the association of SDF1alpha levels with EPC numbers was detected using blood samples taken at the same time point. In the present study, we investigated whether SDF1alpha levels had a long-term predictive value for EPC numbers.
###end p 10
###begin p 11
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 117 121 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kimura1">[27]</xref>
###xml 123 127 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Soriano1">[28]</xref>
###xml 347 351 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Whittaker1">[29]</xref>
###xml 420 421 416 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 439 443 435 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Benboubker1">[30]</xref>
###xml 712 716 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
###xml 230 235 <span type="species:ncbi:9606">human</span>
There is emerging evidence indicating that variation in the human SDF1 gene can have an influence on SDF1alpha levels[27], [28], which was demonstrated clearly to be involved in progenitor cell mobilization and differentiation in human and animal studies. Moreover, previous study showed that EPC number is, at least in part, genetically regulated[29], and the presence of SDF1-3'A allele was a predictive factor of CD34+ cell mobilization[30], which prompt us to hypothesize that the SDF-1 gene single-nucleotide polymorphism (SNP) might involve in their gene transcription and progenitor cell mobilization, differentiation and homing. In the present study, we examined whether there was a relationship between SDF1 gene variation, SDF1alpha level and circulating EPC number. In addition, we tested whether there was also a relationship between variation in the gene encoding the SDF1alpha receptor CXCR4 and EPC number.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Study Population and clinical variables
###end title 13
###begin p 14
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xu1">[31]</xref>
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xu1">[31]</xref>
###xml 320 324 320 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
The subjects of this study were residents of the Bruneck area in the Bolzano Province of Italy, who participated in the Bruneck Study[31]. Details of the Bruneck study have been described previously[31]. DNA samples were available for 826 subjects, and these were genotyped single nucleotide polymorphisms (SNPs) in the SDF1 and CXCR4 genes. Blood samples taken in 2000 (n = 684) and 2005 (n = 574) respectively were used for measurements of SDF1alpha levels. EPC number and function were assessed in blood samples collected in 2005 (n = 571 for EPC number and n = 542 for EPC colonies number respectively). Subjects with and those without EPC number and EPC function assessments did not differ in age, sex and cardiovascular risk factors. The appropriate ethics committees (Autonome Provinz Bozen-Sanitatsbetrieb Bozen Ethikkomittee) approved the study protocol and all study subjects gave their written informed consent before entering the study.
###end p 14
###begin p 15
Systolic and diastolic blood pressure was taken with a standard mercury sphygmomanometer after at least 10 min of rest (mean of three independent measurements). Hypertension was defined as blood pressure >/=140/90 mm Hg or the use of anti-hypertensive drugs. The average number of cigarettes smoked per day was noted for each smoker and ex-smoker. Diabetes was diagnosed according to ADA criteria. Assessment of regular alcohol consumption was performed with a standardized questionnaireand quantified in terms of grams per day (g/day).
###end p 15
###begin title 16
EPC culture assay
###end title 16
###begin p 17
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xiao1">[17]</xref>
EPC numbers in the blood samples were determined as described previously[17]. Briefly, positive stained cells for DiI-Ac-LDL and Lectin were considered to be EPCs on day 5 of culture. The total numbers of EPC per well were counted by two trained independent senior investigators blinded to the clinical details of the subjects. The EPC in a minimum of two wells were counted and the average was then recorded.
###end p 17
###begin title 18
EPC-colony formation unit (CFU) assay
###end title 18
###begin p 19
###xml 51 55 51 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xiao1">[17]</xref>
The EPC-CFU assay performed as described previously[17]. Briefly, PBMNC were resuspended in EPC culture medium (M199 with 20%FCS and antibiotics) and then plated on fibronectin coated 6 well plates at a concentration of 5 million cells per well. The endothelial colonies were counted manually on day 7. Strict guidelines were followed to ensure consistent counting of EPC colonies. Two senior investigators who were blinded to the subjects' clinical status counted the colonies.
###end p 19
###begin title 20
Enzyme-linked immunosorbent assay (ELISA)
###end title 20
###begin p 21
###xml 455 459 447 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Xu2">[32]</xref>
Commercially available SDF1alpha and matrix metalloproteinase-9 (MMP9) ELISA kits (Quantikine, R&D Systems, UK) were used to determine plasma SDF1alpha and MMP9 levels. All ELISA tests were carried out at room temperature on freshly thawed plasma samples. The concentration was determined by comparison with a standard curve, following manufacturer's instruction. Other laboratory parameters and vascular risk factors were all examined by standard methods[32].
###end p 21
###begin title 22
Genotype analyses
###end title 22
###begin p 23
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 277 278 277 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kimura1">[27]</xref>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Soriano1">[28]</xref>
We selected tagging SNPs in the SDF1 and CXCR4 genes from the HapMap database (data release in June 2005). Three SNPs in SDF1 (rs2297630, rs266087 and rs1413519) and two in CXCR4 (rs16832740 and rs12691874) to capture SNPs with a minor allele frequency >0.2 at these loci and R2>0.8 were typed in this study. In addition, we studied the rs266085 SNP which had been reported to influence SDF1 expression[27] and the rs1801157 SNP which had suggested to be associated with plasma SDF1 level[28]. Genomic DNA was extracted from blood samples of the Bruneck study subjects, and genotypes were determined using the TaqMan genotyping method.
###end p 23
###begin title 24
Statistical Analysis
###end title 24
###begin p 25
###xml 430 432 424 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eB</sub>
The data were analyzed using the SPSS 15.0 and BMDP software packages. Continuous variables were presented as means+/-SD or medians (interquartile range), and dichotomous variables as percentages. Correlations between EPC number and EPC-CFU, SDF1alpha level and other parameters were estimated by calculation of crude and partial (age/sex-corrected) Pearson correlation coefficients. Variables with a skewed distribution were logBeB-transformed. Non-parametric tests yielded very similar findings (data not presented). Associations of EPC number, EPC-CFU and SDF1alpha level with SDF1 and CXCR4 genotypes were assessed using generalized linear models adjusted for age and sex. Multivariate models additionally included standard cardiovascular risk factors and the factors associated with SDF1alpha levels (LDL and HDL cholesterol concentrations, smoking, hypertension, diabetes, alcohol consumption, and levels of CRP, MMP9, cystatin C, fibrinogen and homocystein). A Bonferroni correction was performed to account for the multiple comparisons (5 SNPs in SDF1 and 2 in CXCR4) performed.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
Relationship of plasma SDF1alpha level with inflammatory markers and other variables
###end title 27
###begin p 28
###xml 65 74 61 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 65 74 61 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004061-g001"><bold>Figure 1A</bold></xref>
###xml 74 75 70 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 101 102 97 98 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 339 342 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8202;=&#8202;</italic>
###xml 349 350 337 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 560 569 540 549 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 560 569 540 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004061-g001"><bold>Figure 1B</bold></xref>
###xml 1056 1063 1032 1039 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</bold>
###xml 1056 1063 1032 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004061-t001"><bold>Table 1</bold></xref>
###xml 589 594 <span type="species:ncbi:9606">women</span>
###xml 604 609 <span type="species:ncbi:9606">women</span>
###xml 622 625 <span type="species:ncbi:9606">men</span>
Near normal distribution of SDF1alpha was observed in our study (Figure 1A. Kolmogorov-Smirnov p>0.05). Mean SDF1alpha levels in 2000 and 2005 were 2652 pg/ml and 2565 pg/ml, with a range of 880 pg/ml to 5595 pg/ml and 1322 pg/ml to 4174 pg/ml, respectively. SDF1alpha levels in 2000 and 2005 were highly correlated (intraclass correlation = 0.495; P<0.001), indicating that the SDF1alpha level is relatively consistent over time. As expected, both plasma SDF1alpha level measured in 2000 (r = 0.207, p<0.001) and 2005 (r = 0.270, p<0.001) increased with age (Figure 1B) and was higher in women (2619 in women vs. 2497 in men, p = 0.002). Moreover, plasma SDF1alpha level was correlated with alcohol consumption (age/sex-adjusted correlation coefficient r = -0.087, p = 0.042), reticulocyte numbers (r = -0.132, p = 0.002), plasma levels of matrix metalloproteinase-9 (MMP9) (r = 0.146, p = 0.001), C-reactive protein (hsCRP) (r = 0.090, p = 0.037), cystatin C (r = 0.277, p<0.001), fibrinogen (r = 0.159, p<0.001), and homocytein (r = 0.174, p = 0.001). (Table 1)
###end p 28
###begin p 29
Panel A shows near normal distribution of SDF1alpha in the Bruncek study population. Panel B displays the association between SDF-1alpha measured in 2000 and in 2005 and age (r = 0.270, p<0.001). Panel C illustrates the correlation between SDF1alpha levels and EPC number in 2005. The regression line demonstrates clearly that SDF1alpha levels are inverse association with EPC number. Panel D illustrates the association between EPC numbers in 2005 and SDF1alpha level in 2000 (tertile groups). SDF-1 tertile groups are defined as follows: T1<2409, T2 2409-2753 and T3>2753. The box plots indicating EPC number median and IQRs. Notably, EPC numbers are significant associated inversely with SDF-1alpha levels, especially much low EPC number were likely observed in the top tertile group of SDF-1 levels.
###end p 29
###begin title 30
Association between SDF-1alpha level and selected vascular risk factors and laboratory parameters (2005).
###end title 30
###begin p 31
Values are means +/-SD. P values for trend are from age- and sex-adjusted analyses.
###end p 31
###begin title 32
Plasma SDF1alpha level predicts EPC number
###end title 32
###begin p 33
###xml 311 313 307 309 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1C</bold>
###xml 304 313 300 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004061-g001">Figure <bold>1C</bold></xref>
###xml 313 314 309 310 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">)</bold>
###xml 581 590 565 574 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 581 590 565 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004061-g001"><bold>Figure 1D</bold></xref>
EPC number and EPC-CFU number (per 1 ml blood) displayed a non-normal distribution, with the majority of subjects (more than 75%) having 0 to 1000 EPC and 0 to 340 EPC-CFU, respectively. SDF1alpha levels were significantly and inversely associated with EPC number (p<0.001) in samples collected in 2005 (Figure 1C), indicating that SDF1alpha has an influence on EPC number in the general population. Importantly, EPC number in 2005 was also associated with SDF1alpha level in 2000 (p = 0.009), indicating a long-term predictive value of SDF1alpha level for circulating EPC number (Figure 1D). No association between SDF1alpha level and EPC function measured by EPC-CFU was detected in this study.
###end p 33
###begin title 34
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
Association of SDF1 genotyping, plasma SDF1alpha level and circulating EPC number
###end title 34
###begin p 35
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
###xml 95 102 95 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</bold>
###xml 95 102 95 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004061-t002"><bold>Table 2</bold></xref>
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
Allele and genotype frequencies of the SDF1 and CXCR4 SNPs examined in this study are shown in Table 2. The genotype distributions were consistent with Hardy-Weinberg equilibrium.
###end p 35
###begin title 36
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
Genotype and allele frequencies of SDF1 and CXCR4 SNPs studied
###end title 36
###begin p 37
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 202 210 194 202 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</bold>
###xml 202 210 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004061-g002"><bold>Figure 2</bold></xref>
###xml 210 213 202 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> &amp; </bold>
###xml 213 220 205 212 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 213 220 205 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004061-t003"><bold>Table 3</bold></xref>
###xml 705 712 693 700 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</bold>
###xml 705 712 693 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0004061-t003"><bold>Table 3</bold></xref>
The SDF1 rs2297630 SNP was associated with plasma SDF1alpha level (p = 0.002) and circulating EPC number (p = 0.006), with the A/A genotype associating with higher SDF1alpha level and lower EPC number (Figure 2 & Table 3). These associations remained significant after Bonferroni correction for the number of SNPs tested (Bonferroni corrected p = 0.014 and p = 0.042, respectively). The associations also remained significant after adjusting for cardiovascular risk factors and the factors that were associated with SDF1alpha levels, including LDL and HDL cholesterol concentrations, smoking, hypertension, diabetes, alcohol consumption, and levels of hsCRP, MMP9, cystatin C, fibrinogen and homocystein (Table 3).
###end p 37
###begin title 38
Associations of the SDF1 rs2297630 SNP (2000) with EPC number (median and IQR, A) and blood SDF1alpha level (arithmetic means and SD, B) assessed in the 2005 evaluation of the Bruneck Study.
###end title 38
###begin title 39
###xml 65 69 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 74 79 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
Plasma SDF1alpha levels and circulating EPC numbers according to SDF1 and CXCR4 SNP genotypes.
###end title 39
###begin p 40
SDF-1 levels and EPC numbers (per 1 ml blood) are age- and sex-adjusted arithmetic (95%CI) and geometric means (95%CI), respectively. P values are from general linear models adjusted for age and sex and in brackets from models additionally adjusted for canditate vascular risk factors and determinants of SDF-1alpha levels (LDL and HDL cholesterol [mg/dL], smoking [0,1], hypertension [0,1], diabetes [0,1], alcohol consumption [gram/day], homocystein [micromol/L], hsCRP [mg/L], MMP9 [ng/mL], cystatin C [mg/L], fibrinogen [mg/dL]).
###end p 40
###begin p 41
###xml 84 88 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 92 97 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CXCR4</italic>
Plasma SDF1alpha level and circulating EPC number was not associated with the other SDF1 or CXCR4 SNPs tested. No association was observed between any of the SNPs tested and EPC-CFU.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 870 874 846 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 1030 1034 998 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
The population-based, longitudinal design of the Bruneck study allowed us to investigate the relationships between SDF1alpha levels at two different time points (2000 and 2005) and the relationships of the SDF1alpha levels at these different time points with circulating EPC numbers. A key finding from our study is the high degree of correlation the two SDF1alpha measurements in blood samples taken in 2000 and 2005 respectively, suggesting that although SDF1alpha levels are correlated with cardiovascular risk factors, the levels in an individual are relatively consistent over time. In addition, the study revealed an association between SDF1alpha level in 2000 and EPC number in 2005, suggesting a long-term predictive value of SDF1alpha level for EPC number. Another important, novel finding of this study is that there is an association between variation in the SDF1 gene, SDF1alpha level and EPC number, indicating that the inter-individual variability in SDF1alpha level and EPC number is influenced by variation in the SDF1 gene.
###end p 43
###begin p 44
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Nagasawa2">[33]</xref>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Heissig1">[21]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Moore1">[23]</xref>
###xml 441 445 441 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Hiasa1">[25]</xref>
###xml 1370 1371 1362 1363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1507 1511 1495 1499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-DeFalco1">[26]</xref>
###xml 1985 1989 1965 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-DeFalco1">[26]</xref>
###xml 1991 1995 1971 1975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Aiuti1">[34]</xref>
###xml 1996 2000 1976 1980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Hattori1">[36]</xref>
###xml 2206 2210 2182 2186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-DeFalco1">[26]</xref>
###xml 2260 2264 2232 2236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Petit1">[37]</xref>
###xml 73 79 <span type="species:ncbi:10090">murine</span>
###xml 859 864 <span type="species:ncbi:10090">mouse</span>
###xml 888 894 <span type="species:ncbi:9606">humans</span>
###xml 1017 1023 <span type="species:ncbi:9606">humans</span>
###xml 1317 1322 <span type="species:ncbi:10090">mouse</span>
###xml 1503 1507 <span type="species:ncbi:10090">mice</span>
SDF1 is a member of the chemokine CXC subfamily originally isolated from murine bone marrow stromal cells and is expressed also by stromal cells of various tissues[33]. Animal studies have shown that increasing SDF expression by adenovirus gene transfer can induce EPC mobilization from bone marrow into the peripheral blood, thereby increasing circulating EPC numbers[21]-[23], enhancing angiogenesis and blood perfusion in ischemic tissues[25]. These studies have led to the hypothesis that SDF1 plays an important role in EPC mobilization, differentiation and homing. However, data from our study showed that SDF-1alpha levels were inversely, rather than positively, associated with circulating EPC numbers. There are several possible explanations. Almost all of the exiting data that suggest that SDF1alpha can induce circulating EPCs are from studies in mouse, and the situations in humans may be different and more complex. Indeed, a number of studies including the present study have shown that EPC numbers in humans are related to a number of factors including age, gender, smoking, lipid levels, hypertension, diabetes, etc. Secondly, it is possible that the relationship of SDF1 with EPC mobilization, differentiation and homing in the acute phase is different from that in the normal situation. Studies of mouse ischemia models showed that the number of c-Kit+ cells in peripheral blood was lower but the level of SDF1alpha was much higher at 14 days after ischemia, as compared with control mice[26], suggesting that EPCs are mobilized into peripheral blood from bone marrow after the onset of ischemia, but at a later stage, the numbers of mobilized EPC in peripheral blood decrease due to their homing to the ischemic site. Thirdly, because SDF1alpha functions as a chemoattractant for stem/progenitor cells, the SDF1alpha gradient between bone marrow, peripheral blood and injured tissue/sites is crucial for stem/progenitor cell mobilization, differentiation and homing[26], [34]-[36]. It has been reported that stem/progenitor cells in bone marrow and peripheral blood are mobilized and homed to the ischemic or injured tissue due to high SDF1alpha levels in the ischemic or injured tissue[26] and lower levels of SDF-1alpha in the bone marrow[37]. Measurement of plasma SDF1alpha level does not represent the gradient mention above, and therefore, the inverse relationship between plasma SDF1alpha level and circulating EPC number should not be interpreted as in conflict with the notion that SDF1 plays an important role in EPC mobilization, differentiation and homing.
###end p 44
###begin p 45
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Whittaker1">[29]</xref>
###xml 357 361 357 361 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 464 468 460 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 716 720 708 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 1077 1081 1065 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
A recent study showed that there is significant correlation in the number of circulating EPCs between parents and their offsprings, leading to the hypothesis that EPC number is, at least in part, genetically regulated[29]. The results of our study support this hypothesis and indicate that such a genetic influence is likely in part due to variation in the SDF1 gene. In particular, we found that SDF1alpha level and circulating EPC number are associated with the SDF1 gene rs2297630 SNP in the Bruneck study cohort. A potential interpretation for this novel finding is that variation in the SDF1 gene can influence EPC number via an effect on the level of SDF1alpha. The rs2297630 SNP is located in intron 3 of the SDF1 gene. It is possible that the association of this SNP with SDF1alpha level and circulating EPC number has arisen from a direct functional effect of this SNP on SDF1 expression or mRNA splicing. Alternatively, the rs2297630 SNP might be a functionally neutral marker that is in linkage disequilibrium with a functional polymorphism located elsewhere at the SDF1 locus.
###end p 45
###begin p 46
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kimura1">[27]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Soriano1">[28]</xref>
###xml 176 177 176 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 195 199 195 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Benboubker1">[30]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Winkler1">[38]</xref>
###xml 312 316 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Brambilla1">[40]</xref>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Dommange1">[41]</xref>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-deOliveira1">[42]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Dimberg1">[43]</xref>
###xml 497 501 497 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Zafiropoulos1">[44]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Zafiropoulos1">[45]</xref>
###xml 547 551 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Ghilardi1">[46]</xref>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Ide1">[47]</xref>
###xml 710 714 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Lima1">[48]</xref>
###xml 792 796 792 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDF1</italic>
###xml 1086 1090 1072 1076 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Arya1">[49]</xref>
###xml 1092 1096 1078 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Nagasawa3">[50]</xref>
###xml 285 288 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Two other SDF1 SNPs, rs266085 and rs1801157, have been reported to be associated with SDF1 levels[27], [28] and the latter SNP has also been reported to be associated with CD34+ cell mobilization[30]. Some, but not all, studies have suggested that the rs1801157 SNP is associated with HIV infection and AIDS[38]-[40] and there is also evidence suggesting that this SNP is associated with acute myeloid leukaemia[41], chronic myelogenous leukaemia[42], colorectal cancer[43], sporadic breast cancer[44], carotid artery stenosis[45], type I diabetes[46] and systemic lupus erythematosus[47]. However, in vitro experiments show that this SNP (rs1801157) does not have a direct functional effect on SDF1 expression[48], raising the possibility that it may be a marker for a functional SNP at the SDF1 locus due to linkage disequilibrium. This possibility is consistent with the fact that the SDF1 gene is transcribed into two isoforms, SDF1alpha and SDF1beta, and that the rs1801157 SNP is located in the 3' untranslated region of the SDF1beta transcript but not in the SDF1alpha transcript[49], [50]. In the Bruneck study cohort, we found that the rs2297630 SNP, but not the rs266085 or rs1801157 SNP, was associated with SDF1alpha level and EPC number. Taken together, the studies mentioned above and the present study suggest that variation in SDF1 gene has an influence on SDF1 levels. The populations examined in these different studies may have different genetic structure and linkage disequilibrium patterns, which may explain why different SDF1 SNPs were associated with SDF1 levels in the different studies.
###end p 46
###begin p 47
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Shirozu1">[51]</xref>
###xml 806 810 806 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Fadini1">[10]</xref>
###xml 812 816 812 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Tepper1">[11]</xref>
###xml 825 829 825 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Kondo1">[12]</xref>
###xml 851 855 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Grisar1">[13]</xref>
###xml 880 884 880 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004061-Choi1">[14]</xref>
Some particular attentions should be drawn regarding our findings. Firstly, the consideration of the nature of EPC is important, since there is no a unique criteria for identification of EPC, yet. Immense attention regarding the definition of EPC has recently been drawn due to the fact that the characterization and function of EPC isolated with different methodologies were quite different from each other[51]. Myeloid PBMNC derived spindle like EPC, but not circulating CD34+ cells was used to quantify the circulating EPC number in our study. Although a positive relationship between them was reported in the literature, the number of cultured EPC may not always reflect the number of circulating CD34+ and/or KDR+ EPC. Secondly, many diseases have influence on the role of EPC number, such as diabetes[10], [11], smoking[12], rheumatoid arthritis[13] or chronic renal failure[14], among them much reduced EPC number have been reported. Extensive adjustments for cardiovascular risk factors and diseases have been conducted in our study to exclude any potential influence on our findings. Finally, no relationship or association between EPC-CFU and plasma SDF-1alpha levels and SDF-1 gene SNPs were observed in our study, which indicating that neither plasma SDF-1alpha levels nor SDF-1 SNP could affect the proliferation and migration of EPC reflected by their ability to form EPC colonies in the culture.
###end p 47
###begin p 48
In summary, our data indicate that although the SDF1 level and EPC number may both increase in response to acute ischaemic events, the relationship between blood SDF1 level and EPC number is complex and they are inversely correlated in the normal situation as observed in the Bruneck study cohort which was recruited from the general population. Our data also indicate that circulating EPC number is influenced by variation in the SDF1 gene likely via an effect of the genetic variation on SDF1alpha expression. These findings help understand the mechanisms underlying the inter-individual variability in EPC number which has an implication in the pathogenesis of atherosclerosis and other cardiovascular diseases.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
Isolation of putative progenitor endothelial cells for angiogenesis.
###end article-title 50
###begin article-title 51
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
###end article-title 51
###begin article-title 52
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
###end article-title 52
###begin article-title 53
Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia.
###end article-title 53
###begin article-title 54
###xml 68 76 <span type="species:ncbi:9606">patients</span>
Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.
###end article-title 54
###begin article-title 55
Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial.
###end article-title 55
###begin article-title 56
Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.
###end article-title 56
###begin article-title 57
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease.
###end article-title 57
###begin article-title 58
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk.
###end article-title 58
###begin article-title 59
Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus.
###end article-title 59
###begin article-title 60
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.
###end article-title 60
###begin article-title 61
Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers.
###end article-title 61
###begin article-title 62
###xml 69 77 <span type="species:ncbi:9606">patients</span>
Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis.
###end article-title 62
###begin article-title 63
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure.
###end article-title 63
###begin article-title 64
Endothelial progenitor cells during cerebrovascular disease.
###end article-title 64
###begin article-title 65
Circulating endothelial progenitor cells in subjects with erectile dysfunction.
###end article-title 65
###begin article-title 66
Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis-results from a large population-based study.
###end article-title 66
###begin article-title 67
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1.
###end article-title 67
###begin article-title 68
The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract.
###end article-title 68
###begin article-title 69
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development.
###end article-title 69
###begin article-title 70
Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand.
###end article-title 70
###begin article-title 71
Efficient mobilization and recruitment of marrow-derived endothelial and hematopoietic stem cells by adenoviral vectors expressing angiogenic factors.
###end article-title 71
###begin article-title 72
Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1.
###end article-title 72
###begin article-title 73
Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization.
###end article-title 73
###begin article-title 74
Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
###end article-title 74
###begin article-title 75
SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells.
###end article-title 75
###begin article-title 76
Allele-specific transcript quantification detects haplotypic variation in the levels of the SDF-1 transcripts.
###end article-title 76
###begin article-title 77
###xml 142 177 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3'A genotype, and expression of CXCR4 on T lymphocytes: their impact on resistance to human immunodeficiency virus type 1 infection and its progression.
###end article-title 77
###begin article-title 78
Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility.
###end article-title 78
###begin article-title 79
###xml 119 125 <span type="species:ncbi:9606">humans</span>
Association between the SDF1-3'A allele and high levels of CD34(+) progenitor cells mobilized into peripheral blood in humans.
###end article-title 79
###begin article-title 80
Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis.
###end article-title 80
###begin article-title 81
Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population.
###end article-title 81
###begin article-title 82
###xml 44 50 <span type="species:ncbi:10090">murine</span>
###xml 130 136 <span type="species:ncbi:10090">murine</span>
###xml 152 182 <span type="species:ncbi:11676">human immunodeficiency virus 1</span>
Molecular cloning and characterization of a murine pre-B-cell growth-stimulating factor/stromal cell-derived factor 1 receptor, a murine homolog of the human immunodeficiency virus 1 entry coreceptor fusin.
###end article-title 82
###begin article-title 83
###xml 45 50 <span type="species:ncbi:9606">human</span>
The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood.
###end article-title 83
###begin article-title 84
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4.
###end article-title 84
###begin article-title 85
Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells.
###end article-title 85
###begin article-title 86
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4.
###end article-title 86
###begin article-title 87
Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC).
###end article-title 87
###begin article-title 88
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression.
###end article-title 88
###begin article-title 89
###xml 88 123 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.
###end article-title 89
###begin article-title 90
CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemia.
###end article-title 90
###begin article-title 91
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Stromal cell-derived factor-1 chemokine gene variant in blood donors and chronic myelogenous leukemia patients.
###end article-title 91
###begin article-title 92
###xml 81 89 <span type="species:ncbi:9606">patients</span>
Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients.
###end article-title 92
###begin article-title 93
Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer.
###end article-title 93
###begin article-title 94
###xml 40 45 <span type="species:ncbi:9606">human</span>
Genetic control of chemokines in severe human internal carotid artery stenosis.
###end article-title 94
###begin article-title 95
Stromal-cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population.
###end article-title 95
###begin article-title 96
###xml 50 58 <span type="species:ncbi:9606">patients</span>
MCP-1, RANTES, and SDF-1 polymorphisms in Mexican patients with systemic lupus erythematosus.
###end article-title 96
###begin article-title 97
###xml 64 92 <span type="species:ncbi:12721">human immunodeficiency virus</span>
In vitro phenotype of SDF1 gene mutant that delays the onset of human immunodeficiency virus disease in vivo.
###end article-title 97
###begin article-title 98
Molecular cloning and structure of a pre-B-cell growth-stimulating factor.
###end article-title 98
###begin article-title 99
###xml 46 51 <span type="species:ncbi:9606">human</span>
Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene.
###end article-title 99
###begin article-title 100
Working hypothesis to redefine endothelial progenitor cells.
###end article-title 100
###begin p 101
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 101
###begin p 102
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: QX thanks support from the British Heart Foundation and Oak Foundation, and SY thanks support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 102

